A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentric Trial [Etude d'efficacite et d'acceptabilite d'un traitement cholinergique dans l'apathie parkinsonienne "Cholinergic treatment in Parkinsonian Apathy: ChoPA - I"].

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentric Trial [Etude d'efficacite et d'acceptabilite d'un traitement cholinergique dans l'apathie parkinsonienne "Cholinergic treatment in Parkinsonian Apathy: ChoPA - I"].

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2014

At a glance

  • Drugs Rivastigmine (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms CHoPA-I
  • Most Recent Events

    • 23 Apr 2012 Actual patient number is 40 as reported by ClinicalTrials.gov.
    • 23 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Feb 2011 Planned end date changed from 1 Apr 2010 to 1 Jan 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top